VMP 39701611000001108

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Ondansetron 8mg tablets
BNF code 0406000S0AAACAC
Virtual Therapeutic Moiety Ondansetron
Date identifier became valid 26 May 2021
Previous product identifier 322174007
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Ondansetron hydrochloride dihydrate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 372487007
Strength value numerator 8.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Ondansetron 8mg tablets (A A H Pharmaceuticals Ltd)
Ondansetron 8mg tablets (Alissa Healthcare Research Ltd)
Ondansetron 8mg tablets (Alliance Healthcare (Distribution) Ltd)
Ondansetron 8mg tablets (Almus Pharmaceuticals Ltd)
Ondansetron 8mg tablets (Bristol Laboratories Ltd)
Ondansetron 8mg tablets (Cipla EU Ltd)
Ondansetron 8mg tablets (Crescent Pharma Ltd)
Ondansetron 8mg tablets (Ennogen Healthcare International Ltd)
Ondansetron 8mg tablets (Medihealth (Northern) Ltd)
Ondansetron 8mg tablets (Milpharm Ltd)
Ondansetron 8mg tablets (Phoenix Healthcare Distribution Ltd)
Ondansetron 8mg tablets (Relonchem Ltd)
Ondansetron 8mg tablets (Sigma Pharmaceuticals Plc)
Ondansetron 8mg tablets (Teva UK Ltd)
Virtual Medicinal Product Packs
Ondansetron 8mg tablets 10 tablet
Ondansetron 8mg tablets 15 tablet
Ondansetron 8mg tablets 6 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.1.0_20241111000001, imported on 12th November 2024 at 03:53:04.

Feedback